Results overview: Found 4 records in 0.02 seconds.
Articles, 4 records found
Articles 4 records found  
1.
10 p, 2.2 MB Role of B Cell Profile for Predicting Secondary Autoimmunity in Patients Treated With Alemtuzumab / Walo-Delgado, Paulette Esperanza (Hospital Universitario Ramón y Cajal (Madrid)) ; Monreal, Enric (Hospital Universitario Ramón y Cajal (Madrid)) ; Medina, Silvia (Hospital Universitario Ramón y Cajal (Madrid)) ; Quintana, Ester (Institut d'Investigació Biomèdica de Girona) ; Sainz de la Maza, Susana (Hospital Universitario Ramón y Cajal (Madrid)) ; Fernández-Velasco, José Ignacio (Hospital Universitario Ramón y Cajal (Madrid)) ; Lapuente, Paloma (Hospital Universitario Ramón y Cajal (Madrid)) ; Comabella, Manuel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ramió-Torrentà, Lluís (Institut d'Investigació Biomèdica de Girona) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Midaglia, Luciana (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Villarrubia, Noelia (Hospital Universitario Ramón y Cajal (Madrid)) ; Carrasco-Sayalero, Angela (Hospital Universitario Ramón y Cajal (Madrid)) ; Rodríguez-Martín, Eulalia (Hospital Universitario Ramón y Cajal (Madrid)) ; Roldán, Ernesto (Hospital Universitario Ramón y Cajal (Madrid)) ; Meca-Lallana, José (Hospital Universitario Virgen de la Arrixaca (Múrcia)) ; Alvarez-Lafuente, Roberto (Hospital Clínico San Carlos (Madrid)) ; Masjuan, Jaime (Hospital Universitario Ramón y Cajal (Madrid)) ; Costa-Frossard, Lucienne (Hospital Universitario Ramón y Cajal (Madrid)) ; Villar, Luisa M (Hospital Universitario Ramón y Cajal (Madrid)) ; Universitat Autònoma de Barcelona
UDHEBRON.
To explore if baseline blood lymphocyte profile could identify relapsing remitting multiple sclerosis (RRMS) patients at higher risk of developing secondary autoimmune adverse events (AIAEs) after alemtuzumab treatment. [...]

2021 - 10.3389/fimmu.2021.760546
Frontiers in immunology, Vol. 12 (october 2021)  
2.
16 p, 2.6 MB Gut dysbiosis and neuroimmune responses to brain infection with Theiler's murine encephalomyelitis virus / Carrillo-Salinas, Francisco J (Red Española de Esclerosis Múltiple) ; Mestre, L. (Red Española de Esclerosis Múltiple) ; Mecha, Miriam (Red Española de Esclerosis Múltiple) ; Feliú, Ana (Red Española de Esclerosis Múltiple) ; del Campo, Rosa (Instituto Ramón y Cajal de Investigación Sanitaria (Madrid)) ; Villarrubia, Noelia (Instituto Ramón y Cajal de Investigación Sanitaria (Madrid)) ; Espejo, Carmen (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Alvarez-Cermeño, José C (Universidad de Alcalá) ; Villar, L. M. (Instituto Ramón y Cajal de Investigación Sanitaria (Madrid)) ; Guaza, C. (Red Española de Esclerosis Múltiple) ; Universitat Autònoma de Barcelona
Recent studies have begun to point out the contribution of microbiota to multiple sclerosis (MS) pathogenesis. Theiler's murine encephalomyelitis virus induced demyelinating disease (TMEV-IDD) is a model of progressive MS. [...]
2017 - 10.1038/srep44377
Scientific reports, Vol. 7 (03 2017)  
3.
17 p, 8.0 MB Genomic Multiple Sclerosis Risk Variants Modulate the Expression of the ANKRD55 - IL6ST Gene Region in Immature Dendritic Cells / Mena, Jorge (Instituto de Investigación Sanitaria Biocruces Bizkaia) ; Alloza, Iraide (Instituto de Investigación Sanitaria Biocruces Bizkaia) ; Tulloch Navarro, Raquel (Instituto de Investigación Sanitaria Biocruces Bizkaia) ; Aldekoa, Ane (Instituto de Investigación Sanitaria Biocruces Bizkaia) ; Díez García, Javier (Instituto de Investigación Sanitaria Biocruces Bizkaia) ; Villanueva Etxebarria, Ane (Hospital de Galdakao (Usansolo, Biscaia)) ; Lindskog, Cecilia (Uppsala University) ; Antigüedad, Alfredo (Instituto de Investigación Sanitaria Biocruces Bizkaia) ; Boyero, Sabas (Instituto de Investigación Sanitaria Biocruces Bizkaia) ; Mendibe-Bilbao, María del Mar (Instituto de Investigación Sanitaria Biocruces Bizkaia) ; Álvarez de Arcaya, Amaya (Instituto de Investigación Sanitaria Bioaraba (Vitoria, País Basc)) ; Sánchez Menoyo, José Luis (Instituto de Investigación Sanitaria Biocruces Bizkaia) ; Midaglia, Luciana (Hospital Universitari Vall d'Hebron) ; Villarrubia, Noelia (Instituto Ramón y Cajal de Investigación Sanitaria (Madrid)) ; Malhotra, Sunny (Hospital Universitari Vall d'Hebron) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Villar, Luisa M (Instituto Ramón y Cajal de Investigación Sanitaria (Madrid)) ; Comabella, Manuel (Hospital Universitari Vall d'Hebron) ; Vandenbroeck, Koen (Basque Foundation for Science) ; Universitat Autònoma de Barcelona
Intronic single-nucleotide polymorphisms (SNPs) in the ANKRD55 gene are associated with the risk for multiple sclerosis (MS) and rheumatoid arthritis by genome-wide association studies (GWAS). The risk alleles have been linked to higher expression levels of ANKRD55 and the neighboring IL6ST (gp130) gene in CD4 + T lymphocytes of healthy controls. [...]
2022 - 10.3389/fimmu.2021.816930
Frontiers in immunology, Vol. 12 (january 2022)  
4.
12 p, 3.3 MB Adaptive Features of Natural Killer Cells in Multiple Sclerosis / Moreira Villanueva, Antía (Institut Hospital del Mar d'Investigacions Mèdiques) ; Alari-Pahissa, Elvira (Universitat Pompeu Fabra) ; Munteis, Elvira (Institut Hospital del Mar d'Investigacions Mèdiques) ; Vera, Andrea (Institut Hospital del Mar d'Investigacions Mèdiques) ; Zabalza, Ana (Institut Hospital del Mar d'Investigacions Mèdiques) ; Llop, Mireia (Institut Hospital del Mar d'Investigacions Mèdiques) ; Villarrubia, Noelia (Hospital Universitario Ramón y Cajal (Madrid)) ; Costa-Garcia, Marcel (Universitat Pompeu Fabra) ; Alvarez-Lafuente, Roberto (Hospital Clínico San Carlos (Madrid)) ; Villar, Luisa Maria (Hospital Universitario Ramón y Cajal (Madrid)) ; López-Botet, Miguel (Institut Hospital del Mar d'Investigacions Mèdiques) ; Martínez-Rodríguez, José E. (Institut Hospital del Mar d'Investigacions Mèdiques) ; Universitat Autònoma de Barcelona
Human cytomegalovirus (HCMV) has been recently related with a lower susceptibility to multiple sclerosis (MS). HCMV promotes an adaptive development of NK cells bearing the CD94/NKG2C receptor with a characteristic phenotypic and functional profile. [...]
2019 - 10.3389/fimmu.2019.02403
Frontiers in immunology, Vol. 10 (15 2019) , p. 2403  

See also: similar author names
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.